Lilly ventures into pulmonary fibrosis with startup Mediarnews2025-01-10T12:00:05+00:00January 10th, 2025|Endpoints News|
With $120M, GSK-allied Ouro Medicines throws its hat into burgeoning TCE ringnews2025-01-10T11:00:58+00:00January 10th, 2025|Endpoints News|
Intellia to cut workforce by 27%, targets 2027 commercial launchnews2025-01-10T01:22:46+00:00January 10th, 2025|Endpoints News|
Versant unveils Light Horse with $62M and a partnership with Novartisnews2025-01-09T14:32:48+00:00January 9th, 2025|Endpoints News|
Leyden Labs gets $70M to test if nasal sprays can help protect against virusesnews2025-01-09T13:00:32+00:00January 9th, 2025|Endpoints News|
Coave raises €32M Series A despite being two years away from the clinicnews2025-01-09T11:01:05+00:00January 9th, 2025|Endpoints News|
Aiolos team reunites with $411M for new biotech with obesity drugs from Chinanews2025-01-09T07:00:33+00:00January 9th, 2025|Endpoints News|
Gene editing startup Scribe Therapeutics cuts staff by 20%news2025-01-08T17:06:48+00:00January 8th, 2025|Endpoints News|
Solid Bio’s former CEO launches new rare disease startup with €65M Series Anews2025-01-08T16:00:52+00:00January 8th, 2025|Endpoints News|
Roche’s Chugai partners with Swiss ADC biotech Ararisnews2025-01-08T13:00:51+00:00January 8th, 2025|Endpoints News|
